Murae Organisor Ltd
₹0.19▲ +0.00 (+0.00%)
MURAEORGANISORLTD·NSE·Healthcare
Market Cap
38.80 Cr
PE Ratio
4.75
Volume
75,84,257
Day High - Low
0.20 - 0.19
52W High-Low
0.22 - 0.19
₹0.19▲ +0.00 (+0.00%)
Market Cap38.80 Cr
PE Ratio4.75
Volume75,84,257
Day High - Low0.20 - 0.19
52W High-Low0.22 - 0.19
Murae Organisor Ltd (MURAEORGANISORLTD): company summary
Murae Organisor Ltd (MURAEORGANISORLTD) is a micro-cap Healthcare company valued at ₹39 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Murae Organisor Ltd (MURAEORGANISORLTD) is a micro-cap Healthcare company valued at ₹39 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Murae Organisor Ltd last traded at ₹0.19, unchanged on the day.
- Financial performance
- Revenue has been growing strongly at 244.0% a year over three years; profit grew 58.7% a year, behind revenue — margins are under pressure. Return on equity is 5.7%.
- Valuation multiples
- The stock trades at 4.8 times earnings, a discount to the Healthcare median of 32.0.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹0.19 on 25 Mar 2026 (206 days ago). Not a live price.
DocStoX Score
3.2/10
Poor
Fair Value
Sign in to see
ROE
5.69%
Weak
P/E
4.75x
Cheap
Debt / Equity
—
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Mixed
Price performance
Day₹0.19
₹0.20
52W₹0.19
₹0.22
DocStoX take
Supported by growth (8.1) and valuation (7.5), but held back by momentum (0.0). Growth looks strong at 8.1, but that is offset by momentum at 0.0 and quality at 0.7. We are calling it Mixed rather than resolving the conflict for you. The latest financials on file are more than 18 months old, so treat the fundamental measures with caution.
DocStoX score
Low confidence3.2
/10
Poor
Quality
Weak
ROE 5.7%
Valuation
Cheap
P/E 4.8×
Growth
Strong
Revenue +73.1% 5Y CAGR
Risk
Elevated
₹39 cr market cap
Momentum
Weak
0% of 52-week range
At a glance
Market Cap
₹39 Cr
52W High / Low
₹0 / ₹0
Dividend Yield
—
Promoter Holding
0.00%
EPS (TTM)
₹0.04
Book Value
₹1.02
Key highlights
- Revenue compounding 73% a year
- Profit compounding 32% a year
- Undemanding at 5× earnings
- Loss-making in some of the last 5 years
- Quality is weak (0.7/10)
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Murae Organisor Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Murae Organisor Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Murae Organisor Ltd with peers
Murae Organisor Ltd vs Sun Pharmaceutical Industries LimitedMurae Organisor Ltd vs Divi's Laboratories LimitedMurae Organisor Ltd vs Torrent Pharmaceuticals LimitedMurae Organisor Ltd vs Apollo Hospitals Enterprise LimitedMurae Organisor Ltd vs Zydus Lifesciences LimitedMurae Organisor Ltd vs Laurus Labs Limited
Related tools & concepts
Value Murae Organisor Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing